Journal of Cellular and Molecular Medicine · 2015 · 38 citations · 28 references
MedicineImmunologyPharmacologyCell SignalingInflammationPharmacodynamicsAnti-inflammatory PharmacologyAsthma ManagementAsthma PharmacotherapyCytokine BiologyInflammation PharmacologyInflammatory SignalingAirway Inflammation ModulationAsthma ModelsAsthma PathophysiologyBronchoalveolar Lavage AnalysisEosinophil-mediated InflammationEosinophilic Lung InflammationLeukotriene MediatorsP2y12 Receptor Inhibitors
Leukotriene E4 (LTE4) that plays a key role in airway inflammation is expressed on platelets and eosinophils. We investigated whether blocking of the P2Y12 receptor can suppress eosinophilic inflammation in a mouse model of asthma because platelets and eosinophils share this receptor to be activated. BALB/c mice were sensitized by intraperitoneal injection of ovalbumin (OVA), followed by OVA nebulization. On each challenge day, clopidogrel, a P2Y12 antagonist was administered 30 min. before each challenge. Forty-eight hours after the last OVA challenge, mice were assessed for airway hyperresponsiveness (AHR), cell composition and cytokine levels, including chemokine ligand 5 (CCL5), in bronchoalveolar lavage (BAL) fluid. EOL cells were treated with LTE4, with or without clopidogrel treatment, and intracellular and extracellular eosinophil cationic protein (ECP) expressions were measured to find the inhibiting function of P2Y12 antagonist on eosinophilic activation. The levels of P2Y12 expression were increased markedly in the lung homogenates of OVA-sensitized and -challenged mice after platelet depletion. Administration of clopidogrel decreased AHR and the number of airway inflammatory cells, including eosinophils, in BAL fluid following OVA challenge. These results were associated with decreased levels of Th2 cytokines and CCL5. Histological examination showed that inflammatory cells as well as mucus-containing goblet cells were reduced in clopidogrel-administered mice compared to vehicle-treated mice. Clopidogrel inhibited extracellular ECP secretion after LTE4 stimulation in EOL-1 cells. Clopidogrel could prevent development of AHR and airway inflammation in a mouse model of asthma. P2Y12 can be a novel therapeutic target to the suppression of eosinophils in asthma.
28
Characterization of the human cysteinyl leukotriene CysLT1 receptor
Kevin R. Lynch, Gary P. O’Neill, Qingyun Liu et al. · Nature · 1999 · 971 citations
Characterization of the Human Cysteinyl Leukotriene 2 Receptor
Christopher E. Heise, Brian F. O’Dowd, David J. Figueroa et al. · Journal of Biological Chemistry · 2000 · 663 citations · Full text
Medicine, Biochemistry, Pharmacology +11
Leukotriene E4 and granulocytic infiltration into asthmatic airways
L. A. Laitinen, Tari Haahtela, V Vilkka et al. · The Lancet · 1993 · 529 citations